Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Review of CRISPR Tools for Treating Usher Syndrome: Applicability, Safety, Efficiency, and In Vivo Delivery. | Int J Mol Sci | 2023 | 37108761 | PubTator, text mining | PubMed |
| Identification and Functional Analysis of Known and New Mutations in the Transcription Factor KLF1 Linked with β-Thalassemia-like Phenotypes. | Biology (Basel) | 2023 | 37106711 | PubTator, text mining | PubMed |
| HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing. | Nat Commun | 2023 | 37105976 | PubTator, text mining | PubMed |
| Evolutionary constraint and innovation across hundreds of placental mammals. | Science | 2023 | 37104599 | PubTator, text mining | PubMed |
| In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources. | Stem Cell Res Ther | 2023 | 37101221 | PubTator, text mining | PubMed |
| Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies. | Mol Ther Nucleic Acids | 2023 | 37090420 | PubTator, text mining | PubMed |
| Modeling cross-talk of RNA modification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. | MedComm (2020) | 2023 | 37090117 | PubTator, text mining | PubMed |
| Enhancing prime editing efficiency and flexibility with tethered and split pegRNAs. | Protein Cell | 2023 | 37078887 | PubTator, text mining | PubMed |
| Direct correction of haemoglobin E β-thalassaemia using base editors. | Nat Commun | 2023 | 37076455 | PubTator, text mining | PubMed |
| Identification of novel prognostic biomarkers in the TF-enhancer-target regulatory network in hepatocellular carcinoma and immune infiltration analysis. | Front Genet | 2023 | 37065474 | PubTator, text mining | PubMed |
| Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib. | Front Oncol | 2023 | 37064118 | PubTator, text mining | PubMed |
| Advances in CRISPR/Cas gene therapy for inborn errors of immunity. | Front Immunol | 2023 | 37051232 | PubTator, text mining | PubMed |
| Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles' Physicochemical Properties on Responses in Biological Systems. | Polymers (Basel) | 2023 | 37050210 | PubTator, text mining | PubMed |
| In the business of base editors: Evolution from bench to bedside. | PLoS Biol | 2023 | 37043430 | PubTator, text mining | PubMed |
| Ultra-conserved RNA: a novel biological tool with diagnostic and therapeutic potential. | Discov Oncol | 2023 | 37036543 | PubTator, text mining | PubMed |
| Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications. | Mol Biomed | 2023 | 37027099 | PubTator, text mining | PubMed |
| Clinical and laboratory diversity of diffuse large B-cell lymphomas in children with Nijmegen breakage syndrome. | Haematologica | 2023 | 37021541 | PubTator, text mining | PubMed |
| Large-scale mapping and mutagenesis of human transcriptional effector domains. | Nature | 2023 | 37020022 | PubTator, text mining | PubMed |
| Invention of 3Mint for feature grouping and scoring in multi-omics. | Front Genet | 2023 | 37007972 | PubTator, text mining | PubMed |
| Light-activated macromolecular phase separation modulates transcription by reconfiguring chromatin interactions. | Sci Adv | 2023 | 37000871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=23